Last updated 2026-07-20
- Raised $1.9B Undisclosed Round, Aug 2025
- Raised $4.3B Undisclosed Round, Oct 2023
- Raised $3.5B Undisclosed Round, Mar 2021
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$6.5M
total disclosed, rounds participated
Stages
—
About
OrbiMed is a leading global healthcare investment firm with approximately $20 billion in assets under management. The firm invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies. They have offices in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, and Herzliya, Israel.
Portfolio · 1
Investment activity
Portfolio by sector
Undisclosed1
Health Tech & Life Sciences1
Q&A
- What is OrbiMed Healthcare Fund Management's primary investment focus?
- OrbiMed Healthcare Fund Management primarily invests in the Health Tech & Life Sciences sector, as evidenced by its portfolio companies like RDD Pharma and SmartZyme Biopharma.
- Can you name some of OrbiMed Healthcare Fund Management's portfolio companies?
- OrbiMed Healthcare Fund Management's portfolio includes RDD Pharma, which focuses on treating anorectal diseases.
- When did OrbiMed Healthcare Fund Management make its most recent known investment?
- OrbiMed Healthcare Fund Management made a known investment in January 2016.
- What was one of OrbiMed Healthcare Fund Management's earlier investments?
- OrbiMed Healthcare Fund Management made an investment in July 2012.
- What is the typical investment range for OrbiMed Healthcare Fund Management?
- OrbiMed Healthcare Fund Management's investment range is between $6.5M and $7.15M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1989 |
|---|